Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain

Tue, 24th Mar 2020 16:00

(Alliance News) - The follow is a round-up of share dealings by UK company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

Energean Oil & Gas PLC - Company leaders buy shares worth about GBP600,000 in total. Chief Executive Officer Mathios Rigas and Non-Executive Director Efstathios Topouzoglou each buy 29,501 shares at GBP3.25 and GBP3.59 on Thursday last week. Rigas and Topouzoglou buy another 40,000 shares each at GBP3.61 on Friday. Chief Financial Panos Benos buys 14,077 shares at GBP3.59 and GBP3.25 on Friday. Benos buys 20,000 shares at GBP3.61 on Friday.

----------

Pearson PLC - Chair Sidney Taurel buys 100,000 American Depositary Receipts at USD5.38, worth USD537,930, on Monday. Each ADR is equal to one ordinary share. Pearson on Monday paused its share buyback amid uncertainty in the group's businesses that rely on learners and staff accessing physical sites, due to virus lockdowns. To date, GBP167 million of Pearson's GBP350 million share buyback programme has been completed.

----------

CLS Holdings PLC - Sten Mortstedt, an executive director and the office space company's founding shareholder, buys 300,000 shares at 158.5p, worth GBP475,500, on Monday.

----------

InterContinental Hotels Group PLC - Chair Patrick Cescau buys 3,750 at GBP26.59 on Friday last week and 3,780 shares at GBP26.48 on Monday, in total worth GBP199,793. IHG on Friday said demand in its Holiday Inn and Crowne Plaza chains is at the lowest it has ever seen, due to the new coronavirus pandemic.

----------

Share PLC - Non-Executive Director Gareth Thomas buys 117,187 shares at 25.6p and Jessica Thomas buys 68,944 at 29p, together worth GBP49,994, both on Wednesday last week. Gareth Thomas now interested in 404,962 shares, 0.3% of total.

----------

Ruffer Investment Co Ltd - Non-Executive Director Christopher Russell buys 6,974 preference shares at GBP2.15, worth GBP14,994, on Tuesday. Now holds 75,000 shares.

----------

Hikma Pharmaceuticals PLC - Non-Executive Director Cynthia Schwalm buys 1,100 shares at GBP18.19, worth GBP20,009, on Friday last week.

----------

CQS New City High Yield Fund Ltd - Director Duncan Baxter buys 85,715 shares at GBP0.3615, worth GBP31,347, on Monday.

----------

Sportech PLC - CEO Richard McGuire buys 100,000 shares at 11p, worth GBP11,000, on Monday. Now holds 1.1 million shares, 0.6%.

----------

Clinigen Group PLC - CEO Shaun Chilton buys 10,000 shares at 415.5p and CFO Nick Keher buys 6,200 shares at 400p, both on Monday and together worth GBP66,350. "Our share purchases are a strong endorsement of our strategy and underlie our belief in the company and its prospects," Chilton said.

----------

Griffin Mining Ltd - Non-Executive Director Adam Usdan, via Trellus Co LLC, buys 100,000 shares at 32.25p, worth GBP32,250, on Monday. Now holds 33.4 million, 19.2% of total.

----------

European Assets Trust PLC - Director Martin Breuer buys 20,000 shares at GBP0.655, worth GBP13,100, on Monday.

----------

River & Mercantile UK Micro Cap Investment Co Ltd - George Ensor, portfolio manager, buys 20,000 shares at average 97.17p, worth GBP19,434, on Monday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
1 Apr 2022 20:22

IN BRIEF: UK court sanctions Titon takeover of Clinigen

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says Thursday that its takeover by Triton Investment Management Ltd has been sanctioned by the High Court of Justice in England and Wales. Shares will be cancelled from trading on AIM on Tuesday.

Read more
23 Feb 2022 19:06

TRADING UPDATES: IPF swings to profit; Seraphine lowers outlook

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Feb 2022 13:28

Clinigen revenue rises as shareholders approve its acquisition

(Sharecast News) - Pharmaceuticals and service company Clinigen Group reported a 10% improvement in net revenue from continuing operations in its half-year results on Wednesday, or 14% on an organic basis, to £238.1m.

Read more
16 Feb 2022 10:09

IN BRIEF: Clinigen expects acquisition by Triton to complete in April

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceutical services - Says its acquisition by funds managed by Triton Investment Management Ltd is likely to complete in early April, with its shares due to be cancelled on AIM on April 5. The deal and timeline are subject to antitrust and foreign investment approvals. Triton, a private equity firm submitted a cash offer of 925 pence per share, valuing Clinigen at GBP1.3 billion, which was approved by shareholders last Tuesday. The latest date for completion is September 8.

Read more
9 Feb 2022 10:38

IN BRIEF: Clinigen signs global distribution deal for Qinlock

IN BRIEF: Clinigen signs global distribution deal for Qinlock

Read more
8 Feb 2022 14:41

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

IN BRIEF: Clinigen shareholders approve takeover by Triton funds

Read more
17 Jan 2022 10:05

Triton increases takeover bid for Clinigen to GBP1.3 billion

Triton increases takeover bid for Clinigen to GBP1.3 billion

Read more
17 Jan 2022 07:29

Triton makes 'increased and final' 925p bid for Clinigen

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.

Read more
12 Jan 2022 11:49

Clinigen reiterates guidance after 'solid' first half

(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of between 5% and 10% in a trading update on Wednesday.

Read more
12 Jan 2022 11:13

Clinigen holds earnings growth guidance after solid first half

Clinigen holds earnings growth guidance after solid first half

Read more
11 Jan 2022 14:59

CORRECT: UK shareholder meetings calendar - next 7 days

CORRECT: UK shareholder meetings calendar - next 7 days

Read more
11 Jan 2022 14:46

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Dec 2021 15:55

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
8 Dec 2021 11:56

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid

Read more
8 Dec 2021 11:45

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.